article thumbnail

Acupuncture combined with multiple therapies for angina pectoris: a systematic review and network meta-analysis

Frontiers in Cardiovascular Medicine

ObjectiveAcupuncture combined with multiple treatment modalities has been widely employed for treating angina pectoris. This paper compared the efficacy of acupuncture combined with multiple treatment modalities for angina pectoris by network meta-analysis (NMA).MethodsAs and Stata (version 16.0).Results46

Angina 64
article thumbnail

ORBITA 2: The power of PCI revealed for stable angina

Cardiology Update

The ORBITA-2 trial ( NCT03742050 ) investigated the efficacy of Percutaneous Coronary Intervention (PCI) compared to placebo in 301 patients with stable angina. At the 12-week mark, the PCI group exhibited a significantly lower mean angina score (2.9) 2023;Epub ahead of print. 2023;Epub ahead of print. 3.47; p<0.001).

Angina 52
article thumbnail

Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis

Frontiers in Cardiovascular Medicine

Background Tongxinluo capsule (TXLC) is a common drug for treating angina pectoris of coronary heart disease (CHD). In recent years, many systematic reviews (SRs) and meta-analyses (MAs) have reported the efficacy and safety of TXLC for improving angina symptoms in patients with CHD.

Angina 64
article thumbnail

PCI for stable angina : Sham trials are welcome, but not OMT shaming trials !

Dr. S. Venkatesan MD

After a series of experiments in animals and peripheral vessels, he proved with a single patient N-1 study that effectively treated refractory LAD angina in a 38-year-old man in 1977. No one has questioned the efficacy of PCI for true angina with a critical lesion. ORBITA-2 came in 2023. 2023 Dec 21;389(25):2319-2330.

Angina 52
article thumbnail

Decoding the Menace Within: Unraveling Myocardial Bridges and Exercise-Induced Ischemia

Cardiology Update

The perplexing landscape of angina with nonobstructive coronary arteries (ANOCA) encompasses diverse pathophysiological entities, including coronary microvascular disease (CMD), coronary artery spasm, and the enigmatic myocardial bridging (MB). Original article: Sinha A et al. Circ Cardiovasc Interv.

Exercise 119
article thumbnail

Prospective cohort study for evaluating the safety and efficacy of mobile, motorized enhanced extracorporeal counterpulsation in refractory angina patients

The American Journal of Cardiology

Publication date: Available online 16 December 2023 Source: The American Journal of Cardiology Author(s): Jooyeon Lee, Jaewon Oh, In-Cheol Kim, Seonhwa Lee, Se-Eun Kim, Chan Joo Lee, Hyungseop Kim, Seok-Min Kang

Angina 52
article thumbnail

Management and outcomes of spontaneous coronary artery dissection: a systematic review of the literature

Frontiers in Cardiovascular Medicine

Methods The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed when we extensively searched three electronic databases: PubMed, ScienceDirect, and Web of Science, for studies that compared conservative vs. invasive revascularization treatment outcomes for patients with SCAD from 2003 to 2023.

SCAD 75